10.1016/j.bbi.2021.11.023 124 TilgH.AdolphT
July 18, 2025: Chinese Obesity Drug Outperforms Zepbound in Helping Patients Lose Weight, Trials Show A new obesity drug, HRS9531, made by the Chinese company Hengrui Pharma may help patients lose more weight than when on Zepbound
Furthermore, in some pathological conditions, normal tissues may exhibit elevated enzyme activity or redox levels, increasing off-target risks
Always verify the dose printed on the pen matches your prescription, and double-check the pen color as a secondary confirmation
Key Products: Canvuparatide (MBX 2109), once-weekly parathyroid hormone peptide prodrug for chronic hypoparathyroidism
Journal of neurochemistry, 169(12), e70316